Loading…

Low risk of locoregional recurrence of primary breast carcinoma after treatment with a modification of the Halsted radical mastectomy and selective use of radiotherapy

BACKGROUND The purpose of the current study was to evaluate the locoregional recurrence rate after treatment of patients with operable breast carcinoma with a modification of the Halsted radical mastectomy and the selective use of radiotherapy and to identify risk factors for locoregional recurrence...

Full description

Saved in:
Bibliographic Details
Published in:Cancer 1999-04, Vol.85 (8), p.1773-1781
Main Authors: Bijker, Nina, Rutgers, Emiel J. T., Peterse, Johannes L., van Dongen, Joop A., Hart, August A. M., Borger, Jacques H., Kroon, Bin B. R.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c3988-a5e87ad289cac905f903d937711c2f0deeddcbc3877fda7291777d5286b6fd983
container_end_page 1781
container_issue 8
container_start_page 1773
container_title Cancer
container_volume 85
creator Bijker, Nina
Rutgers, Emiel J. T.
Peterse, Johannes L.
van Dongen, Joop A.
Hart, August A. M.
Borger, Jacques H.
Kroon, Bin B. R.
description BACKGROUND The purpose of the current study was to evaluate the locoregional recurrence rate after treatment of patients with operable breast carcinoma with a modification of the Halsted radical mastectomy and the selective use of radiotherapy and to identify risk factors for locoregional recurrence. METHODS Between 1979–1987, 691 consecutive patients underwent mastectomy after a negative biopsy of the axillary apical lymph nodes. The median age of the patients was 59 years (range, 26–89 years). The clinical tumor size was < 2 cm in 72 patients, 2–5 cm in 387 patients, and >5 cm in 169 patients; 16 patients had a T4 tumor. Surgery was comprised of a modification of the Halsted radical mastectomy, including at least part of the pectoralis major muscle and the entire pectoralis minor muscle, in 573 patients; 303 patients had positive axillary lymph nodes. Adjuvant radiotherapy to the chest wall and regional lymph nodes was given to 74 patients, whereas an additional 414 patients underwent irradiation to the internal mammary and medial supraclavicular lymph nodes. The median follow‐up was 91 months. RESULTS The actuarial overall survival rate was 82% at 5 years and 63% at 10 years. The 10‐year chest wall and regional lymph node control rates, including patients with prior distant failures, were 95% and 94%, respectively. The only two significant prognostic factors for locoregional recurrence on multivariate analysis were lymph node status and pathologic tumor size. CONCLUSIONS Excellent locoregional control can be achieved with a modified technique of radical mastectomy in patients with negative apical biopsy and the selective use of comprehensive radiotherapy. These results may serve as a reference outcome for comparison with other locoregional treatment strategies. Cancer 1999;85:1773–81. © 1999 American Cancer Society. Excellent locoregional control was achieved using a modification of the Halsted radical mastectomy and the selective use of comprehensive radiotherapy.
doi_str_mv 10.1002/(SICI)1097-0142(19990415)85:8<1773::AID-CNCR18>3.0.CO;2-M
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69722461</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69722461</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3988-a5e87ad289cac905f903d937711c2f0deeddcbc3877fda7291777d5286b6fd983</originalsourceid><addsrcrecordid>eNqFkWuLEzEUhgdR3Lr6FyQfRHY_TM2lM0mqCGW8bKFrwQsofghpcsbNOjOpyYylv8i_acbWCygIgXDOec-bk_Nk2YLgKcGYPjp7s6yW5wRLnmMyo2dESolnpDgXxVw8IZyz-XyxfJZXr6rXRDxlUzyt1o9pfnkjm_zquplNMMYiL2bs_Ul2J8brFHJasNvZCcGUsoLTSfZt5XcouPgZ-Ro13vgAn5zvdIMCmCEE6AyMpW1wrQ57tAmgY4-MDsZ1vtVI1z0E1Kd030LXo53rr5BGrbeudkb3yWzs768AXegm9mBR0DZVGtQmJzC9b_dIdxZFaFLkvgIa4o83R51PjUFv93ezW3Vqh3vH-zR79-L52-oiX61fLqvFKjdMCpHrAgTXlgpptJG4qCVmVjLOCTG0xhbAWrMxTHBeW82pTMvktqCi3JS1lYKdZg8PvtvgvwwQe9W6aKBpdAd-iKqUnNJZSZLww0Fogo8xQK2OK1IEq5GiUiNFNfJQIw_1k6IS6aiRolKJojpQVExhVa0VVZfJ-_5xiGHTgv3D-YAtCR4cBTqmTdZBd8bF3zpelgUeP_PxINu5BvZ_Dfj_-f453jHDvgMge8qi</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69722461</pqid></control><display><type>article</type><title>Low risk of locoregional recurrence of primary breast carcinoma after treatment with a modification of the Halsted radical mastectomy and selective use of radiotherapy</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><source>EZB Electronic Journals Library</source><creator>Bijker, Nina ; Rutgers, Emiel J. T. ; Peterse, Johannes L. ; van Dongen, Joop A. ; Hart, August A. M. ; Borger, Jacques H. ; Kroon, Bin B. R.</creator><creatorcontrib>Bijker, Nina ; Rutgers, Emiel J. T. ; Peterse, Johannes L. ; van Dongen, Joop A. ; Hart, August A. M. ; Borger, Jacques H. ; Kroon, Bin B. R.</creatorcontrib><description>BACKGROUND The purpose of the current study was to evaluate the locoregional recurrence rate after treatment of patients with operable breast carcinoma with a modification of the Halsted radical mastectomy and the selective use of radiotherapy and to identify risk factors for locoregional recurrence. METHODS Between 1979–1987, 691 consecutive patients underwent mastectomy after a negative biopsy of the axillary apical lymph nodes. The median age of the patients was 59 years (range, 26–89 years). The clinical tumor size was &lt; 2 cm in 72 patients, 2–5 cm in 387 patients, and &gt;5 cm in 169 patients; 16 patients had a T4 tumor. Surgery was comprised of a modification of the Halsted radical mastectomy, including at least part of the pectoralis major muscle and the entire pectoralis minor muscle, in 573 patients; 303 patients had positive axillary lymph nodes. Adjuvant radiotherapy to the chest wall and regional lymph nodes was given to 74 patients, whereas an additional 414 patients underwent irradiation to the internal mammary and medial supraclavicular lymph nodes. The median follow‐up was 91 months. RESULTS The actuarial overall survival rate was 82% at 5 years and 63% at 10 years. The 10‐year chest wall and regional lymph node control rates, including patients with prior distant failures, were 95% and 94%, respectively. The only two significant prognostic factors for locoregional recurrence on multivariate analysis were lymph node status and pathologic tumor size. CONCLUSIONS Excellent locoregional control can be achieved with a modified technique of radical mastectomy in patients with negative apical biopsy and the selective use of comprehensive radiotherapy. These results may serve as a reference outcome for comparison with other locoregional treatment strategies. Cancer 1999;85:1773–81. © 1999 American Cancer Society. Excellent locoregional control was achieved using a modification of the Halsted radical mastectomy and the selective use of comprehensive radiotherapy.</description><identifier>ISSN: 0008-543X</identifier><identifier>EISSN: 1097-0142</identifier><identifier>DOI: 10.1002/(SICI)1097-0142(19990415)85:8&lt;1773::AID-CNCR18&gt;3.0.CO;2-M</identifier><identifier>PMID: 10223572</identifier><identifier>CODEN: CANCAR</identifier><language>eng</language><publisher>New York: John Wiley &amp; Sons, Inc</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents, Hormonal - therapeutic use ; Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; Biological and medical sciences ; Biopsy ; Breast ; breast carcinoma ; Breast Neoplasms - drug therapy ; Breast Neoplasms - epidemiology ; Breast Neoplasms - pathology ; Breast Neoplasms - radiotherapy ; Breast Neoplasms - surgery ; Chemotherapy, Adjuvant ; Combined Modality Therapy ; Disease-Free Survival ; Female ; Humans ; Life Tables ; local recurrence ; Lymphatic Metastasis - prevention &amp; control ; Mastectomy, Modified Radical ; Medical sciences ; Middle Aged ; modified radical mastectomy ; Neoplasm Recurrence, Local - drug therapy ; Neoplasm Recurrence, Local - epidemiology ; Neoplasm Recurrence, Local - prevention &amp; control ; Neoplasm Staging ; Netherlands - epidemiology ; radiotherapy ; Radiotherapy, Adjuvant ; regional recurrence ; Retrospective Studies ; Risk ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgery of the genital tract and mammary gland ; Survival Analysis ; Survival Rate ; Thoracic Neoplasms - epidemiology ; Thoracic Neoplasms - secondary ; Treatment Outcome</subject><ispartof>Cancer, 1999-04, Vol.85 (8), p.1773-1781</ispartof><rights>Copyright © 1999 American Cancer Society</rights><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3988-a5e87ad289cac905f903d937711c2f0deeddcbc3877fda7291777d5286b6fd983</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1766508$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10223572$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bijker, Nina</creatorcontrib><creatorcontrib>Rutgers, Emiel J. T.</creatorcontrib><creatorcontrib>Peterse, Johannes L.</creatorcontrib><creatorcontrib>van Dongen, Joop A.</creatorcontrib><creatorcontrib>Hart, August A. M.</creatorcontrib><creatorcontrib>Borger, Jacques H.</creatorcontrib><creatorcontrib>Kroon, Bin B. R.</creatorcontrib><title>Low risk of locoregional recurrence of primary breast carcinoma after treatment with a modification of the Halsted radical mastectomy and selective use of radiotherapy</title><title>Cancer</title><addtitle>Cancer</addtitle><description>BACKGROUND The purpose of the current study was to evaluate the locoregional recurrence rate after treatment of patients with operable breast carcinoma with a modification of the Halsted radical mastectomy and the selective use of radiotherapy and to identify risk factors for locoregional recurrence. METHODS Between 1979–1987, 691 consecutive patients underwent mastectomy after a negative biopsy of the axillary apical lymph nodes. The median age of the patients was 59 years (range, 26–89 years). The clinical tumor size was &lt; 2 cm in 72 patients, 2–5 cm in 387 patients, and &gt;5 cm in 169 patients; 16 patients had a T4 tumor. Surgery was comprised of a modification of the Halsted radical mastectomy, including at least part of the pectoralis major muscle and the entire pectoralis minor muscle, in 573 patients; 303 patients had positive axillary lymph nodes. Adjuvant radiotherapy to the chest wall and regional lymph nodes was given to 74 patients, whereas an additional 414 patients underwent irradiation to the internal mammary and medial supraclavicular lymph nodes. The median follow‐up was 91 months. RESULTS The actuarial overall survival rate was 82% at 5 years and 63% at 10 years. The 10‐year chest wall and regional lymph node control rates, including patients with prior distant failures, were 95% and 94%, respectively. The only two significant prognostic factors for locoregional recurrence on multivariate analysis were lymph node status and pathologic tumor size. CONCLUSIONS Excellent locoregional control can be achieved with a modified technique of radical mastectomy in patients with negative apical biopsy and the selective use of comprehensive radiotherapy. These results may serve as a reference outcome for comparison with other locoregional treatment strategies. Cancer 1999;85:1773–81. © 1999 American Cancer Society. Excellent locoregional control was achieved using a modification of the Halsted radical mastectomy and the selective use of comprehensive radiotherapy.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antineoplastic Agents, Hormonal - therapeutic use</subject><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Biopsy</subject><subject>Breast</subject><subject>breast carcinoma</subject><subject>Breast Neoplasms - drug therapy</subject><subject>Breast Neoplasms - epidemiology</subject><subject>Breast Neoplasms - pathology</subject><subject>Breast Neoplasms - radiotherapy</subject><subject>Breast Neoplasms - surgery</subject><subject>Chemotherapy, Adjuvant</subject><subject>Combined Modality Therapy</subject><subject>Disease-Free Survival</subject><subject>Female</subject><subject>Humans</subject><subject>Life Tables</subject><subject>local recurrence</subject><subject>Lymphatic Metastasis - prevention &amp; control</subject><subject>Mastectomy, Modified Radical</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>modified radical mastectomy</subject><subject>Neoplasm Recurrence, Local - drug therapy</subject><subject>Neoplasm Recurrence, Local - epidemiology</subject><subject>Neoplasm Recurrence, Local - prevention &amp; control</subject><subject>Neoplasm Staging</subject><subject>Netherlands - epidemiology</subject><subject>radiotherapy</subject><subject>Radiotherapy, Adjuvant</subject><subject>regional recurrence</subject><subject>Retrospective Studies</subject><subject>Risk</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Surgery of the genital tract and mammary gland</subject><subject>Survival Analysis</subject><subject>Survival Rate</subject><subject>Thoracic Neoplasms - epidemiology</subject><subject>Thoracic Neoplasms - secondary</subject><subject>Treatment Outcome</subject><issn>0008-543X</issn><issn>1097-0142</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNqFkWuLEzEUhgdR3Lr6FyQfRHY_TM2lM0mqCGW8bKFrwQsofghpcsbNOjOpyYylv8i_acbWCygIgXDOec-bk_Nk2YLgKcGYPjp7s6yW5wRLnmMyo2dESolnpDgXxVw8IZyz-XyxfJZXr6rXRDxlUzyt1o9pfnkjm_zquplNMMYiL2bs_Ul2J8brFHJasNvZCcGUsoLTSfZt5XcouPgZ-Ro13vgAn5zvdIMCmCEE6AyMpW1wrQ57tAmgY4-MDsZ1vtVI1z0E1Kd030LXo53rr5BGrbeudkb3yWzs768AXegm9mBR0DZVGtQmJzC9b_dIdxZFaFLkvgIa4o83R51PjUFv93ezW3Vqh3vH-zR79-L52-oiX61fLqvFKjdMCpHrAgTXlgpptJG4qCVmVjLOCTG0xhbAWrMxTHBeW82pTMvktqCi3JS1lYKdZg8PvtvgvwwQe9W6aKBpdAd-iKqUnNJZSZLww0Fogo8xQK2OK1IEq5GiUiNFNfJQIw_1k6IS6aiRolKJojpQVExhVa0VVZfJ-_5xiGHTgv3D-YAtCR4cBTqmTdZBd8bF3zpelgUeP_PxINu5BvZ_Dfj_-f453jHDvgMge8qi</recordid><startdate>19990415</startdate><enddate>19990415</enddate><creator>Bijker, Nina</creator><creator>Rutgers, Emiel J. T.</creator><creator>Peterse, Johannes L.</creator><creator>van Dongen, Joop A.</creator><creator>Hart, August A. M.</creator><creator>Borger, Jacques H.</creator><creator>Kroon, Bin B. R.</creator><general>John Wiley &amp; Sons, Inc</general><general>Wiley-Liss</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19990415</creationdate><title>Low risk of locoregional recurrence of primary breast carcinoma after treatment with a modification of the Halsted radical mastectomy and selective use of radiotherapy</title><author>Bijker, Nina ; Rutgers, Emiel J. T. ; Peterse, Johannes L. ; van Dongen, Joop A. ; Hart, August A. M. ; Borger, Jacques H. ; Kroon, Bin B. R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3988-a5e87ad289cac905f903d937711c2f0deeddcbc3877fda7291777d5286b6fd983</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antineoplastic Agents, Hormonal - therapeutic use</topic><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Biopsy</topic><topic>Breast</topic><topic>breast carcinoma</topic><topic>Breast Neoplasms - drug therapy</topic><topic>Breast Neoplasms - epidemiology</topic><topic>Breast Neoplasms - pathology</topic><topic>Breast Neoplasms - radiotherapy</topic><topic>Breast Neoplasms - surgery</topic><topic>Chemotherapy, Adjuvant</topic><topic>Combined Modality Therapy</topic><topic>Disease-Free Survival</topic><topic>Female</topic><topic>Humans</topic><topic>Life Tables</topic><topic>local recurrence</topic><topic>Lymphatic Metastasis - prevention &amp; control</topic><topic>Mastectomy, Modified Radical</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>modified radical mastectomy</topic><topic>Neoplasm Recurrence, Local - drug therapy</topic><topic>Neoplasm Recurrence, Local - epidemiology</topic><topic>Neoplasm Recurrence, Local - prevention &amp; control</topic><topic>Neoplasm Staging</topic><topic>Netherlands - epidemiology</topic><topic>radiotherapy</topic><topic>Radiotherapy, Adjuvant</topic><topic>regional recurrence</topic><topic>Retrospective Studies</topic><topic>Risk</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Surgery of the genital tract and mammary gland</topic><topic>Survival Analysis</topic><topic>Survival Rate</topic><topic>Thoracic Neoplasms - epidemiology</topic><topic>Thoracic Neoplasms - secondary</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bijker, Nina</creatorcontrib><creatorcontrib>Rutgers, Emiel J. T.</creatorcontrib><creatorcontrib>Peterse, Johannes L.</creatorcontrib><creatorcontrib>van Dongen, Joop A.</creatorcontrib><creatorcontrib>Hart, August A. M.</creatorcontrib><creatorcontrib>Borger, Jacques H.</creatorcontrib><creatorcontrib>Kroon, Bin B. R.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bijker, Nina</au><au>Rutgers, Emiel J. T.</au><au>Peterse, Johannes L.</au><au>van Dongen, Joop A.</au><au>Hart, August A. M.</au><au>Borger, Jacques H.</au><au>Kroon, Bin B. R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Low risk of locoregional recurrence of primary breast carcinoma after treatment with a modification of the Halsted radical mastectomy and selective use of radiotherapy</atitle><jtitle>Cancer</jtitle><addtitle>Cancer</addtitle><date>1999-04-15</date><risdate>1999</risdate><volume>85</volume><issue>8</issue><spage>1773</spage><epage>1781</epage><pages>1773-1781</pages><issn>0008-543X</issn><eissn>1097-0142</eissn><coden>CANCAR</coden><abstract>BACKGROUND The purpose of the current study was to evaluate the locoregional recurrence rate after treatment of patients with operable breast carcinoma with a modification of the Halsted radical mastectomy and the selective use of radiotherapy and to identify risk factors for locoregional recurrence. METHODS Between 1979–1987, 691 consecutive patients underwent mastectomy after a negative biopsy of the axillary apical lymph nodes. The median age of the patients was 59 years (range, 26–89 years). The clinical tumor size was &lt; 2 cm in 72 patients, 2–5 cm in 387 patients, and &gt;5 cm in 169 patients; 16 patients had a T4 tumor. Surgery was comprised of a modification of the Halsted radical mastectomy, including at least part of the pectoralis major muscle and the entire pectoralis minor muscle, in 573 patients; 303 patients had positive axillary lymph nodes. Adjuvant radiotherapy to the chest wall and regional lymph nodes was given to 74 patients, whereas an additional 414 patients underwent irradiation to the internal mammary and medial supraclavicular lymph nodes. The median follow‐up was 91 months. RESULTS The actuarial overall survival rate was 82% at 5 years and 63% at 10 years. The 10‐year chest wall and regional lymph node control rates, including patients with prior distant failures, were 95% and 94%, respectively. The only two significant prognostic factors for locoregional recurrence on multivariate analysis were lymph node status and pathologic tumor size. CONCLUSIONS Excellent locoregional control can be achieved with a modified technique of radical mastectomy in patients with negative apical biopsy and the selective use of comprehensive radiotherapy. These results may serve as a reference outcome for comparison with other locoregional treatment strategies. Cancer 1999;85:1773–81. © 1999 American Cancer Society. Excellent locoregional control was achieved using a modification of the Halsted radical mastectomy and the selective use of comprehensive radiotherapy.</abstract><cop>New York</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>10223572</pmid><doi>10.1002/(SICI)1097-0142(19990415)85:8&lt;1773::AID-CNCR18&gt;3.0.CO;2-M</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0008-543X
ispartof Cancer, 1999-04, Vol.85 (8), p.1773-1781
issn 0008-543X
1097-0142
language eng
recordid cdi_proquest_miscellaneous_69722461
source Wiley-Blackwell Read & Publish Collection; EZB Electronic Journals Library
subjects Adult
Aged
Aged, 80 and over
Antineoplastic Agents, Hormonal - therapeutic use
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Biological and medical sciences
Biopsy
Breast
breast carcinoma
Breast Neoplasms - drug therapy
Breast Neoplasms - epidemiology
Breast Neoplasms - pathology
Breast Neoplasms - radiotherapy
Breast Neoplasms - surgery
Chemotherapy, Adjuvant
Combined Modality Therapy
Disease-Free Survival
Female
Humans
Life Tables
local recurrence
Lymphatic Metastasis - prevention & control
Mastectomy, Modified Radical
Medical sciences
Middle Aged
modified radical mastectomy
Neoplasm Recurrence, Local - drug therapy
Neoplasm Recurrence, Local - epidemiology
Neoplasm Recurrence, Local - prevention & control
Neoplasm Staging
Netherlands - epidemiology
radiotherapy
Radiotherapy, Adjuvant
regional recurrence
Retrospective Studies
Risk
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Surgery of the genital tract and mammary gland
Survival Analysis
Survival Rate
Thoracic Neoplasms - epidemiology
Thoracic Neoplasms - secondary
Treatment Outcome
title Low risk of locoregional recurrence of primary breast carcinoma after treatment with a modification of the Halsted radical mastectomy and selective use of radiotherapy
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T23%3A33%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Low%20risk%20of%20locoregional%20recurrence%20of%20primary%20breast%20carcinoma%20after%20treatment%20with%20a%20modification%20of%20the%20Halsted%20radical%20mastectomy%20and%20selective%20use%20of%20radiotherapy&rft.jtitle=Cancer&rft.au=Bijker,%20Nina&rft.date=1999-04-15&rft.volume=85&rft.issue=8&rft.spage=1773&rft.epage=1781&rft.pages=1773-1781&rft.issn=0008-543X&rft.eissn=1097-0142&rft.coden=CANCAR&rft_id=info:doi/10.1002/(SICI)1097-0142(19990415)85:8%3C1773::AID-CNCR18%3E3.0.CO;2-M&rft_dat=%3Cproquest_cross%3E69722461%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3988-a5e87ad289cac905f903d937711c2f0deeddcbc3877fda7291777d5286b6fd983%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=69722461&rft_id=info:pmid/10223572&rfr_iscdi=true